HR 5278 United States House · 119th Congress

Affordable Inhalers and Nebulizers Act of 2025

HR 5278, the Affordable Inhalers and Nebulizers Act of 2025, limits out-of-pocket costs for patients using prescription inhalers and nebulizers to treat asthma and chronic obstructive pulmonary disease (COPD). The bill requires private health insurance plans, Medicare Part B and Part D, and new payment programs to cover these products with no deductible and a maximum cost of $15 per 30-day supply. It directly affects patients with asthma or COPD who rely on covered inhalers, nebulizers, and related equipment like spacers. The law applies to all specified inhaler products (including medications and administration equipment) and takes effect for plan years beginning January 1, 2026.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Sep 2025

Committee Review

Floor Vote

President

Introduced Sep 10, 2025 Last action Sep 10, 2025

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Sep 10, 2025

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Sep 10, 2025

Introduced

Introduced in House

lower

1 primary · 13 co-sponsors